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Abstract
We assessed 4045 ambulatory surgery patients for surgical site infection (SSI) using claims-based 
triggers for medical chart review. Of 98 patients flagged by codes suggestive of SSI, 35 had 
confirmed SSIs. SSI rates ranged from 0 to 3.2% for common procedures. Claims may be useful 
for SSI surveillance following ambulatory surgery.
Most operations in the United States are now performed in the outpatient setting.1 However, 
little is known about infection rates following these procedures or how best to monitor for 
these complications, despite reports of serious lapses in infection control practices at 
ambulatory surgery centers.2,3
Traditional surgical site infection (SSI) surveillance methods, which focus on inpatient 
hospitalization and readmission at the facility where the procedure was performed, are likely 
inadequate for monitoring complications following ambulatory surgery. Our prior work has 
shown that claims data can improve SSI surveillance following inpatient surgery 
procedures.4–7 We evaluated a surveillance strategy of using routinely collected claims data 
followed by medical record review among ambulatory surgery patients in a large managed 
care organization.
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This was a retrospective cohort study across 3.7 million member-years for Harvard Pilgrim 
Health Care members who received care through Atrius Health, an alliance of 6 medical 
groups in Massachusetts. We identified adult members (≥18 years old) who had Current 
Procedural Terminology (CPT) or International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) procedure codes for selected common ambulatory 
surgical procedures (Table 1) performed from January 1, 2000, through December 31, 2008, 
with no overnight hospital stay following surgery. We searched claims records for acute care 
hospitalizations and/or any ICD-9-CM or CPT code suggestive of SSI (SSI code) within 60 
days (Table 1). Patients who had undergone another ambulatory procedure within the 
previous 6 months were excluded.
We reviewed medical records for all patients with hospitalizations or SSI codes to assess for 
SSI, using the CDC’s National Healthcare Safety Network surveillance definitions.8 We 
estimated the sensitivity and positive predictive value (PPV) of hospitalization and SSI 
codes to identify medical record–confirmed SSIs (the gold standard) for each procedure. 
Sensitivity calculations were based on the total number of confirmed SSIs identified using 
hospitalization or SSI code triggers. We estimated SSI rates for each procedure and 
calculated 95% CIs for overall SSI rates and pooled sensitivity/PPV using the Wilson score 
method. Analyses were performed using SAS, version 9.3 (SAS Institute).
RESULTS
There were 4045 targeted ambulatory procedures performed during the study period (Table 
2). The mean age in the cohort was 51 years and 55% of the patients were women. 
Herniorrhaphies (N = 1370) and cholecystectomies (N = 1126) accounted for the majority 
(62%) of procedures. Two hundred twenty records were flagged for review: 98 (2.4%) were 
associated with an SSI code and 146 (3.6%) were associated with a hospitalization (24 had 
both a hospitalization and SSI code).
There were 36 confirmed SSIs (25 superficial incisional, 2 deep incisional, and 9 organ/
space), identified at a median of 12 days after index procedures (range, 2–57 days). 
Confirmed SSI rates ranged from 0% for laminectomies (0/325 procedures) and pubovaginal 
slings (0/486) to 3.2% (4/126) for appendectomies, for an overall rate of 0.9% (36/4045 
procedures) (95% CI, 0.6%–1.2%). Outpatient SSI codes alone identified 20 superficial, 1 
deep, and 2 organ/space SSIs; inpatient SSI codes alone identified 5 superficial, 1 deep, and 
5 organ/space SSIs; and hospitalizations alone identified 2 organ/space SSIs.
SSI codes identified 35 of 36 confirmed SSIs (sensitivity, 97%; 95% CI, 86%–99%) with a 
PPV of 36% (95% CI, 27%–45%). Outpatient SSI codes identified 23 of 36 cases 
(sensitivity, 64%; 95% CI, 48%–78%) with a PPV of 30% (95% CI, 21%–41%) whereas 
inpatient SSI codes identified 11 of 36 cases (sensitivity, 31%; 95% CI, 18%–47%) with a 
PPV of 52% (95% CI, 32%–72%). Hospitalization claims had an overall sensitivity of 36% 
(13 of 36 cases) (95% CI, 22%–52%) and PPV of 8.9% (95% CI, 5.3%–15%). The 
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combination of hospitalization or any SSI code had a PPV of 16% (95% CI, 12%–22%) 
(Table 2).
DISCUSSION
We found that the overall risk of SSI is not insignificant following several common 
ambulatory surgical procedures. SSI rates for pacemaker placement (0.4%), 
cholecystectomy (0.5%), herniorrhaphy (1.3%), and appendectomy (3.2%) procedures in our 
study were comparable with or higher than rates reported to National Healthcare Safety 
Network for those procedures following inpatient surgery during 2006–2008 (0.4%, 0.6%, 
1.2%, and 1.4%, respectively).9 Furthermore, we found that claims codes from both 
inpatient and ambulatory encounters can identify potential SSIs, including deep incisional 
and organ/space SSIs, following ambulatory procedures. On the basis of the PPV of 36%, 
focusing on the 2.4% of patients who receive an SSI code following ambulatory surgery 
would efficiently identify approximately 1 true case of SSI of every 3 cases reviewed. In 
contrast, screening based on postprocedure hospitalizations alone had low sensitivity (36%), 
underscoring the fact that many ambulatory surgery SSIs are superficial incisional and 
managed in the outpatient setting, and a PPV of only 8.9%, reflecting a predominance of 
non–SSI-related causes for hospitalization.
As surgical procedures increasingly shift to ambulatory settings, tracking postoperative 
complications will become critical, particularly given the relevance of healthcare-associated 
infections to reimbursement and interfacility comparisons. Hospital-based surveillance 
methods are inadequate because SSIs following ambulatory surgery often do not require 
hospitalization; more than half of the confirmed SSIs in our study (23 of 36 cases) were 
managed in an outpatient setting. Furthermore, if hospitalized, patients who underwent 
surgery at a freestanding ambulatory surgery center will likely be treated at a different 
facility. A screening strategy using claims data is appealing since these data are routinely 
collected by payers and reflect healthcare encounters in the outpatient and inpatient setting. 
Claims-based SSI surveillance based on encounters across the spectrum of healthcare could 
potentially be used by insurers or quality improvement organizations to assess the burden of 
infectious complications following ambulatory surgery and to target areas for improvement.
Recently, Owens et al. also found relatively low but non-negligible SSI rates (0.5% overall) 
among low-risk ambulatory surgery patients using administrative data from 8 states, but they 
did not perform medical record review to verify National Healthcare Safety Network SSI 
criteria.10 Our results suggest that claims data alone might significantly overestimate true 
SSI rates but can be used to flag a reasonable number of high-likelihood cases for record 
review.
Our study has several important limitations. First, the number of patients meeting screening 
criteria was small, limiting the precision of results. Second, for this exploratory study, we 
did not extract detailed comorbidity data and SSI estimates were not risk-adjusted, limiting 
comparison with other populations. Assessing methods for meaningful SSI risk adjustment 
among ambulatory surgery patients will be important to incorporate into future studies. 
Third, because we reviewed only cases that had an SSI code or hospitalization, our 
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screening strategy may have led to an underestimation of SSI rates and overestimation of the 
sensitivity/specificity of claims if SSIs occurred among those without a claims-based trigger. 
Prior studies comparing the performance of routine SSI surveillance with claims-enhanced 
surveillance, however, have shown that claims-based screening identified the majority of 
SSIs following a variety of inpatient surgical procedures.4–7 Fourth, we examined 1 practice 
in 1 managed care organization. Additional research is needed to evaluate the 
generalizability of these results.
In conclusion, ambulatory surgery SSI rates may mirror inpatient rates for some common 
procedures but are likely to be underestimated using traditional hospital-based surveillance. 
On the basis of the results of this study, claims-based SSI surveillance in conjunction with 
targeted medical record review may be a useful strategy following ambulatory surgery.
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TABLE 1
Current Procedural Terminology (CPT) or International Classification of Diseases, Ninth 
Revision, Clinical Modification
(ICD-9-CM) Codes Used to Identify Selected Ambulatory Surgery Procedures and to Screen for Surgical Site 
Infection (SSI Codes)
ICD-9-CM or CPT codes
Ambulatory procedures
 Anterior cruciate ligament 
repair
CPT: 29888
 Appendectomy ICD-9-CM: 47.0, 47.01, 47.09, 47.2, 47.91, 47.92, 47.99; CPT: 44960, 44970, 44979, 49315, 56315
 Cholecystectomy ICD-9-CM: 51.03, 51.04, 51.13, 51.21–51.24; CPT: 47420, 47425, 47440, 47460, 47550, 47562–64, 47600, 
47605, 47610–47612, 47620, 47630, 49310–11, 56324, 56340–56342
 Herniorrhaphy ICD-9-CM: 17.11–17.13, 17.21–17.24, 53.00–53.05, 53.10–53.17, 53.21, 53.29, 53.31, 53.39, 53.41–53.43, 
53.49, 53.51, 53.59, 53.61–53.63, 53.69; CPT: 49520–21, 49525, 49550, 49553, 49555, 49557, 49560–61, 
49565–66, 49568, 49570, 49572, 49585, 49587, 49659
 Laminectomy ICD-9-CM: 03.01, 03.02, 03.09; CPT: 63001, 63005, 63011–12, 63015–63017, 63020, 63030, 63040, 63042, 
63045–63047, 63056, 63075
 Pacemaker placement ICD-9-CM: 17.51,17.52, 37.70–37.77, 37.79–37.83, 37.85–37.87, 37.89, 37.94–37.99, 00.50–00.54; CPT: 
33206–08, 33212–33218, 33220, 33222–23, 33233–35, 33240–41, 33244, 33249
 Pubovaginal sling ICD-9-CM:59.4–59.6, 59.71; CPT: 57288, 57423
SSI screening codes
 Procedures ICD-9-CM: 86.01, 83.49, 86.22, 86.28, 86.04, 86.09, 96.59, 91.71–91.73; CPT: 10160–61, 10140, 10180, 
11000, 11005, 11008, 11040–44, 12020–21, 13100–02, 13131–33, 13160, 14000–01, 14040–41, 15100, 
15120, 15200, 15240, 15852, 20000, 20005, 21501, 21510, 21920, 21925, 22010, 97597–98, 97602, 97605–
06
 Diagnoses ICD-9-CM: 320, 324, 567.22, 567.38, 614.3, 682.2, 682.6–682.9, 711.06, 730.00, 730.05–730.08, 995.90–
995.92, 996.60–996.63, 996.65–996.67, 996.69, 998.31, 998.32, 998.5, 998.51, 998.59, 998.83, 998.9
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